Most of the patients show an extremely gentle, self‐limiting viral respiratory illness, numerous clinical signs in serious patients are novel to COVID‐19, like extreme lymphopenia and eosinopenia, broad pneumonia, a "cytokine storm" prompting intense respiratory misery disorder, endothelitis, thromboembolic entanglements, and multi organ disappointment. SARS-CoV-2, although not being a circulatory infection, spread from the respiratory lot coming about in multi organ disappointments and thrombotic confusions, the signs of deadly Coronavirus. Here, we profiled 52 patients with serious Coronavirus and exhibited that coursing platelets of 19 out 20 non-survivor patients contain SARS-CoV-2 in vigorous relationship with lethal result. This requires persuading proof regarding the advantages of presenting the new test, unmistakably reflected in less medical clinic confirmations, less extra examinations or potentially less centre visits. Painstakingly planned review and money saving advantage concentrates on in pertinent patient gatherings should exhibit that presenting the biomarker conveys an improved and more powerful clinical pathway. Great steadiness of the biomarker in pertinent physiological networks is fundamental to keep away from the requirement for extraordinary handling. Scientifically, mechanization is fundamental in present day high-throughput clinical research facilities.